Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BVS NASDAQ:SLNO NASDAQ:TMDX NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$9.28$9.67$5.81▼$11.25$775.20M0.72526,848 shs734,901 shsSLNOSoleno Therapeutics$53.01$46.64$29.43▼$90.32$2.76B-2.221.75 million shsN/ATMDXTransMedics Group$68.93$97.13$60.10▼$156.00$2.38B2.071.92 million shs1.15 million shsWRBYWarby Parker$25.10+0.0%$23.70$14.96▼$31.00$2.69B1.953.57 million shs1.47 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus0.00%-12.29%-8.03%+7.16%+927,999,900.00%SLNOSoleno Therapeutics0.00%0.00%+0.55%+33.69%-31.06%TMDXTransMedics Group0.00%+9.07%-37.86%-48.81%-44.52%WRBYWarby Parker0.00%-12.68%+9.83%+13.27%+26.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$9.28$9.67$5.81▼$11.25$775.20M0.72526,848 shs734,901 shsSLNOSoleno Therapeutics$53.01$46.64$29.43▼$90.32$2.76B-2.221.75 million shsN/ATMDXTransMedics Group$68.93$97.13$60.10▼$156.00$2.38B2.071.92 million shs1.15 million shsWRBYWarby Parker$25.10+0.0%$23.70$14.96▼$31.00$2.69B1.953.57 million shs1.47 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus0.00%-12.29%-8.03%+7.16%+927,999,900.00%SLNOSoleno Therapeutics0.00%0.00%+0.55%+33.69%-31.06%TMDXTransMedics Group0.00%+9.07%-37.86%-48.81%-44.52%WRBYWarby Parker0.00%-12.68%+9.83%+13.27%+26.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 3.00Buy$14.0050.86% UpsideSLNOSoleno Therapeutics 2.08Hold$76.6744.63% UpsideTMDXTransMedics Group 2.50Moderate Buy$135.0095.85% UpsideWRBYWarby Parker 2.64Moderate Buy$29.5017.53% UpsideCurrent Analyst Ratings BreakdownLatest BVS, SLNO, WRBY, and TMDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026WRBYWarby Parker CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform5/22/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$14.005/19/2026WRBYWarby Parker Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/19/2026SLNOSoleno Therapeutics Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral5/11/2026WRBYWarby Parker Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Hold (C-)5/11/2026SLNOSoleno Therapeutics Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026WRBYWarby Parker UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$25.00 ➝ $27.005/8/2026WRBYWarby Parker Telsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$32.00 ➝ $33.005/7/2026WRBYWarby Parker BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$32.00 ➝ $34.005/6/2026TMDXTransMedics Group Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$152.00 ➝ $124.005/6/2026TMDXTransMedics Group TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$190.00 ➝ $120.00(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$568.09M1.36$1.27 per share7.28$2.80 per share3.31SLNOSoleno Therapeutics$285.01M9.69$0.43 per share124.10$9.51 per share5.57TMDXTransMedics Group$605.49M3.93$3.93 per share17.55$14.29 per share4.82WRBYWarby Parker$871.91M3.08$0.63 per share39.88$3.51 per share7.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus$22.73M$0.4122.6310.431.184.94%29.97%9.52%N/ASLNOSoleno Therapeutics$20.89M$1.7729.959.89N/A33.70%22.85%18.25%8/5/2026 (Estimated)TMDXTransMedics Group$190.29M$4.4015.6718.99N/A27.04%22.38%8.46%7/30/2026 (Estimated)WRBYWarby Parker$1.64M$0.021,255.6357.05N/A0.15%2.30%1.18%8/6/2026 (Estimated)Latest BVS, SLNO, WRBY, and TMDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million5/6/2026Q1 2026BVSBioventus$0.09$0.15+$0.06$0.04N/A$132.09 million5/5/2026Q1 2026TMDXTransMedics Group$0.62$0.30-$0.32$0.20$174.44 million$173.93 million3/5/2026Q4 2025BVSBioventus$0.22$0.24+$0.02$0.21N/A$157.90 million2/25/2026Q4 2025SLNOSoleno Therapeutics$0.64$0.80+$0.16$0.80$88.55 million$91.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.081.691.13SLNOSoleno Therapeutics0.105.625.32TMDXTransMedics Group1.706.746.19WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%SLNOSoleno Therapeutics97.42%TMDXTransMedics Group99.67%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBVSBioventus33.00%SLNOSoleno Therapeutics6.40%TMDXTransMedics Group6.90%WRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20083.54 million55.97 millionN/ASLNOSoleno Therapeutics3052.12 million48.78 millionOptionableTMDXTransMedics Group21034.56 million32.18 millionOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableBVS, SLNO, WRBY, and TMDX HeadlinesRecent News About These CompaniesSimplify Asset Management Inc. Buys New Position in Warby Parker Inc. $WRBYMay 25 at 5:50 AM | marketbeat.comThe Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind...May 24 at 8:30 AM | marketbeat.comNeil Harris Blumenthal Sells 63,040 Shares of Warby Parker (NYSE:WRBY) StockMay 22 at 7:30 AM | insidertrades.com47,191 Shares in Warby Parker Inc. $WRBY Purchased by Fortis Group Advisors LLCMay 22 at 4:14 AM | marketbeat.comWarby Parker (NYSE:WRBY) CEO Sells $1,893,091.20 in StockMay 21, 2026 | marketbeat.comWarby Parker Offers Glimpse of Google-Powered Smart GlassesMay 20, 2026 | pymnts.comWarby Parker slides as investors compare its smart glasses to the Meta Ray-Ban lineMay 20, 2026 | msn.comWarby Parker Stock Slumps 11% as Questions Cloud Its Google Gemini AI Eyewear RevealMay 19, 2026 | barrons.comWarby Parker (NYSE:WRBY) Trading Down 6.6% - Here's WhyMay 19, 2026 | marketbeat.comGoogle and Samsung's Warby Parker and Gentle Monster Glasses Are Coming This FallMay 19, 2026 | cnet.comWarby Parker Unveils First Intelligent Eyewear DesignMay 19, 2026 | businesswire.comTimesSquare Capital Management LLC Boosts Stock Holdings in Warby Parker Inc. $WRBYMay 19, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells $574,961.17 in StockMay 18, 2026 | americanbankingnews.comUBS Remains a Hold on Warby Parker (WRBY)May 17, 2026 | theglobeandmail.comWarby Parker (NYSE:WRBY) Director Sells $140,205.33 in StockMay 16, 2026 | insidertrades.comWe Think Warby Parker's (NYSE:WRBY) Robust Earnings Are ConservativeMay 15, 2026 | finance.yahoo.comWarby Parker Sees Unusually High Options Volume (NYSE:WRBY)May 14, 2026 | marketbeat.comWarby Parker: Post-Earnings Strength Not Supported By Earnings (Rating Downgrade)May 13, 2026 | seekingalpha.comWarby Parker: Sales Slowdown And Margin DeleverageMay 13, 2026 | seekingalpha.comUBS Group AG Trims Stock Position in Warby Parker Inc. $WRBYMay 13, 2026 | marketbeat.comFirst Eagle Investment Management LLC Reduces Position in Warby Parker Inc. $WRBYMay 13, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Alphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026BVS, SLNO, WRBY, and TMDX Company DescriptionsBioventus NASDAQ:BVS$9.28 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$9.27 -0.01 (-0.11%) As of 05/22/2026 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.Soleno Therapeutics NASDAQ:SLNO$53.01 0.00 (0.00%) As of 05/19/2026Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.TransMedics Group NASDAQ:TMDX$68.93 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$68.53 -0.40 (-0.58%) As of 05/22/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.Warby Parker NYSE:WRBY$25.10 +0.01 (+0.04%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$24.88 -0.23 (-0.90%) As of 05/22/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
